Ad
related to: asln stock price
Search results
Bears are Losing Control Over ASLAN Pharmaceuticals Ltd. (ASLN), Here's Why It's a 'Buy' Now
Zacks via Yahoo Finance· 1 year agoASLAN Pharmaceuticals Ltd. (ASLN) witnesses a hammer chart pattern, indicating support found by the...
ASLAN Pharmaceuticals Limited's (NASDAQ:ASLN) recent 25% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Given the large stake in the stock by institutions, ASLAN Pharmaceuticals' stock price...
ASLAN (ASLN) Down 25% on Mixed Results From Skin Disease Study
Zacks via Yahoo Finance· 11 months agoASLAN (ASLN) reports mixed results from a mid-stage study of eblasakimab in adult patients with...
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
Zacks via Yahoo Finance· 3 months agoASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with...
Apellis' (APLS) Q3 Earnings Miss Estimates, Revenues Top Mark
Zacks via Yahoo Finance· 2 years agoApellis Pharmaceuticals, Inc. APLS reported a loss per share of $1.75 for third-quarter 2022, wider...
What's Going On With ASLAN Pharmaceuticals Stock Today?
Benzinga via Yahoo Finance· 11 months agoASLAN Pharmaceuticals Ltd (NASDAQ: ASLN) released topline data from its TREK-AD Phase 2b...
Indexes Mixed After Economic Data; Warren Buffett Stock Rises On Big Win
Investor's Business Daily· 10 months agoMajor indexes were mixed in late afternoon trading. The Dow Jones Industrial Average was off session...
ASLAN Pharmaceuticals Presents New Data From Atopic Dermatitis Candidate
Benzinga via Yahoo Finance· 2 years agoASLAN Pharmaceuticals (NASDAQ: ASLN) announced the presentation of new translational eblasakimab...
ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients
Benzinga via Yahoo Finance· 2 years agoASLAN Pharmaceuticals (NASDAQ: ASLN) plans to initiate a new clinical trial of eblasakimab for...
